A detailed history of Ubs Oconnor LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 52,045 shares of IDYA stock, worth $1.83 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
52,045
Holding current value
$1.83 Million
% of portfolio
0.14%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$34.2 - $47.13 $770,526 - $1.06 Million
-22,530 Reduced 30.21%
52,045 $2.28 Million
Q4 2023

Feb 14, 2024

SELL
$24.59 - $35.83 $1.27 Million - $1.85 Million
-51,574 Reduced 40.88%
74,575 $2.65 Million
Q3 2023

Nov 14, 2023

SELL
$21.07 - $29.77 $316,050 - $446,550
-15,000 Reduced 10.63%
126,149 $3.4 Million
Q2 2023

Aug 14, 2023

BUY
$13.33 - $25.53 $1.88 Million - $3.6 Million
141,149 New
141,149 $3.32 Billion
Q1 2023

May 15, 2023

BUY
$13.49 - $18.72 $315,382 - $437,654
23,379 Added 20.23%
138,949 $1.91 Million
Q4 2022

Feb 14, 2023

BUY
$14.47 - $18.17 $513,077 - $644,271
35,458 Added 44.26%
115,570 $0
Q3 2022

Nov 14, 2022

BUY
$9.24 - $15.79 $740,234 - $1.26 Million
80,112 New
80,112 $1.2 Billion

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.69B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.